July 23, 2021

On July 23, biopharmaceutical company Theratechnologies Inc. established an at-the-market equity program allowing it to issue and sell up to $50 million of its common shares to the public at the prevailing market price. Led by Partner Martin C. Glass, the team included Partners Geoffrey M. Davis and Louis E. Fogel and Associate Kristen M. Iglesias.